title: Cost-analysis of an intensive care unit closure due to an imipenem-resistant oxa-23 Acinetobacter baumannii outbreak.
authors.forename: R
authors.initials: R
authors.lastname: Garlantézec
authors.forename: C
authors.initials: C
authors.lastname: Bourigault
authors.forename: J M
authors.initials: JM
authors.lastname: Boles
authors.forename: G
authors.initials: G
authors.lastname: Prat
authors.forename: R
authors.initials: R
authors.lastname: Baron
authors.forename: J M
authors.initials: JM
authors.lastname: Tonnelier
authors.forename: M
authors.initials: M
authors.lastname: Cosse
authors.forename: M
authors.initials: M
authors.lastname: Lefevre
authors.forename: S
authors.initials: S
authors.lastname: Jourdain
authors.forename: G
authors.initials: G
authors.lastname: Lelay
authors.forename: L
authors.initials: L
authors.lastname: Daniel
authors.forename: M
authors.initials: M
authors.lastname: Virmaux
authors.forename: I
authors.initials: I
authors.lastname: Le Du
authors.forename: D
authors.initials: D
authors.lastname: Tande
authors.forename: A
authors.initials: A
authors.lastname: Renault
authors.forename: B
authors.initials: B
authors.lastname: Lejeune
mesh_terms: D000151:Acinetobacter Infections / Q000188:drug therapy* / Q000453:epidemiology / Q000517:prevention & control; D040981:Acinetobacter baumannii / Q000187:drug effects*; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D003365:Costs and Cost Analysis; D004196:Disease Outbreaks; D005602:France / Q000453:epidemiology; D006271:Health Facility Closure; D006784:Hospitals, Teaching; D006801:Humans; D015378:Imipenem / Q000494:pharmacology*; D017053:Infection Control / Q000191:economics / Q000379:methods / Q000592:standards; D007362:Intensive Care Units / Q000191:economics*; D001618:beta-Lactamases
chemical_list: D000900:Anti-Bacterial Agents; D015378:Imipenem; C466679:beta-lactamase OXA-23; D001618:beta-Lactamases